Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 3, 2026

PayPal transformed digital payments. Why the California fintech giant is now struggling

View original at finance.yahoo.com
PayPal transformed digital payments. Why the California fintech giant is now struggling A PayPal sign shown in San José. (Jeff Chiu / Associated Press) PayPal, once the cutting-edge trailblazer of digital payments, is struggling to cash in on consumer clicks like it used to…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The transition and push for branded checkout really has not paid off

    60% confidence

  • The former CEO's pace of change and execution over two years didn't meet the board's expectations

    60% confidence

  • The slowdown in branded checkout is partly attributed to the K-shaped economy, affecting middle-income and lower-income customers

    60% confidence

  • PayPal sits at the center of this change, and he looks forward to leading the team to accelerate the delivery of new innovations

    60% confidence

  • The payments industry is changing faster than ever, driven by new technologies, evolving regulations, competitive landscape, and AI acceleration reshaping commerce

    60% confidence

  • The vast majority of PayPal's profits come from the branded checkout button, and the yield from branded checkout is multiples of any other product

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
PayPal transformed digital payments. Why the California fintech giant is now struggling — Source | Via News | Finance Via News